What is plasmapheresis?

Therapeutic apheresis is the separation of various components of the blood that play a pathogenic role in some conditions and diseases. Isolation of white blood cells or leukophores in leukemias, erythrocytapheresis or isolation of red blood cells in sickle cell anemia and plasmapheresis or isolation of plasma used in various diseases. In therapeutic plasma exchange (TPE), a large amount of plasma is taken from the patient in each session and, depending on the clinical condition of the FFP, albumin and crystalloid materials such as isotonic saline are replaced.

Learn more about plasmapheresis:

Identified cases through which plasmapheresis improves the clinical condition is: 

A rapid removal of circulating factors that are directly pathogenic, such as antiGBM antibody in Goodpasture disease or light chains in multiple myeloma. In addition, plasmapheresis can reduce the inflammatory process by removing high molecular weight substances that are involved in intensifying the inflammatory process, such as complement system components and cytokines. On the other hand, with the help of plasmapheresis, it is possible to inject large amounts of plasma to the patient to replace the lost material. 

Plasmapheresis improves the clearance of antibodies and immune complexes by unblocking the reticuloendothelial system. Also, by changing idiotype 0 dialysis, anti-idiotype antibody/changes the concentration of antibody to an antigen to facilitate the removal of the immune complex. 

Stimulation of lymphocyte colonies and as a result of their sensitivity to cytotoxic substances used with plasmapheresis. 


Therefore, to use plasmapheresis, at least one of the following conditions must be met: - Substances that must be removed from the body have a molecular weight above 15,000. Materials with lower molecular weight can be more easily removed by other methods such as hemofiltration. ـ 

The pathogen material has a long half-life so that its uptake by plasmapheresis increases its clearance. For example, the half-life of IgG is approximately 21 days, and if we can completely stop its production with cytotoxic drugs, we expect its plasma concentration to decrease by 50% after 21 days. 

The material to be harvested is toxic and resistant to other treatments or the effect of treatment on them is delayed. Because most diseases in which plasmapheresis is beneficial are of immunological origin, immunosuppressive therapy is usually necessary to inhibit the production of toxic substances. Factors affecting the rate of removal of toxic substances by plasmapheresis: - Lifespan of immunoglobulins: The half-life of immunoglobulins determines the amount and rate of increase in plasma levels. The ratio of intravascular to extravascular concentrations so that the more restricted the release of immunoglobulin into the vessel, the more efficient and rapid it's uptake by plasmapheresis.

Nilasalamat Paydar, as the main representative of European companies producing all types of cartridges and hemoperfusion filters, and using more than one hundred trained nursing experts, is ready to provide quality services to all loved ones who need this important treatment for their critically ill patients.

:Related articles

Plasmapheresis is a process in which the liquid part of the blood, or plasma, is separated from the blood cells. Typically, the plasma is replaced with another solution such

To receive advice regarding this service, preferably via WhatsApp or fill out the form below to receive your response as soon as possible.

Address: Tehran, Jordan, Black Tower Building (Iranian Business Center), 11th Floor, Unit 4

Postal code: 1966944899

Company office phone: 0212621477

Sales Unit Phone: 09121204673

Consulting unit phone: 09128874845

.All rights of this website are reserved and belong to Nila Salamat Paydar Institute©